1. Home
  2. SCOR vs CGTX Comparison

SCOR vs CGTX Comparison

Compare SCOR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCOR
  • CGTX
  • Stock Information
  • Founded
  • SCOR 1999
  • CGTX 2007
  • Country
  • SCOR United States
  • CGTX United States
  • Employees
  • SCOR N/A
  • CGTX N/A
  • Industry
  • SCOR Business Services
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCOR Consumer Discretionary
  • CGTX Health Care
  • Exchange
  • SCOR Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • SCOR 34.7M
  • CGTX 30.0M
  • IPO Year
  • SCOR 2007
  • CGTX 2021
  • Fundamental
  • Price
  • SCOR $8.10
  • CGTX $0.64
  • Analyst Decision
  • SCOR Buy
  • CGTX Strong Buy
  • Analyst Count
  • SCOR 3
  • CGTX 6
  • Target Price
  • SCOR $12.83
  • CGTX $8.30
  • AVG Volume (30 Days)
  • SCOR 43.2K
  • CGTX 891.3K
  • Earning Date
  • SCOR 03-05-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • SCOR N/A
  • CGTX N/A
  • EPS Growth
  • SCOR N/A
  • CGTX N/A
  • EPS
  • SCOR N/A
  • CGTX N/A
  • Revenue
  • SCOR $356,212,000.00
  • CGTX N/A
  • Revenue This Year
  • SCOR N/A
  • CGTX N/A
  • Revenue Next Year
  • SCOR $2.92
  • CGTX N/A
  • P/E Ratio
  • SCOR N/A
  • CGTX N/A
  • Revenue Growth
  • SCOR N/A
  • CGTX N/A
  • 52 Week Low
  • SCOR $4.89
  • CGTX $0.34
  • 52 Week High
  • SCOR $20.42
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • SCOR 66.50
  • CGTX 43.76
  • Support Level
  • SCOR $6.82
  • CGTX $0.60
  • Resistance Level
  • SCOR $7.49
  • CGTX $0.82
  • Average True Range (ATR)
  • SCOR 0.59
  • CGTX 0.06
  • MACD
  • SCOR 0.18
  • CGTX -0.02
  • Stochastic Oscillator
  • SCOR 88.87
  • CGTX 18.56

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: